Trial Profile
A multicentre randomised and comparative trial to assess the tolerance, efficacy and pharmacokinetics of escalating doses of Casodex versus castration in the treatment of advanced carcinoma of the prostate
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Sep 2006
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 21 Sep 2006 Status change
- 29 Nov 2005 New trial record.